

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.29867660 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.72609247 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.72609247 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.25675073 |
| 5 | NADH metabolic process (GO:0006734) | 5.11891721 |
| 6 | respiratory electron transport chain (GO:0022904) | 5.11720489 |
| 7 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.01211515 |
| 8 | proline biosynthetic process (GO:0006561) | 5.00504679 |
| 9 | electron transport chain (GO:0022900) | 4.99339511 |
| 10 | cullin deneddylation (GO:0010388) | 4.97465796 |
| 11 | tricarboxylic acid cycle (GO:0006099) | 4.96436266 |
| 12 | oxidative phosphorylation (GO:0006119) | 4.93485892 |
| 13 | protein maturation by protein folding (GO:0022417) | 4.93071903 |
| 14 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.92467973 |
| 15 | proteasome assembly (GO:0043248) | 4.87424543 |
| 16 | protein complex biogenesis (GO:0070271) | 4.65444461 |
| 17 | protein deneddylation (GO:0000338) | 4.64327580 |
| 18 | DNA unwinding involved in DNA replication (GO:0006268) | 4.60242433 |
| 19 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.59706665 |
| 20 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.59706665 |
| 21 | NADH dehydrogenase complex assembly (GO:0010257) | 4.59706665 |
| 22 | DNA deamination (GO:0045006) | 4.59364838 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 4.49346913 |
| 24 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.33262428 |
| 25 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.13646422 |
| 26 | amino acid salvage (GO:0043102) | 4.04183575 |
| 27 | L-methionine salvage (GO:0071267) | 4.04183575 |
| 28 | L-methionine biosynthetic process (GO:0071265) | 4.04183575 |
| 29 | regulation of mitochondrial translation (GO:0070129) | 3.95835008 |
| 30 | pentose-phosphate shunt (GO:0006098) | 3.85287719 |
| 31 | oxaloacetate metabolic process (GO:0006107) | 3.79712907 |
| 32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.77821639 |
| 33 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.76974946 |
| 34 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.76447587 |
| 35 | GDP-mannose metabolic process (GO:0019673) | 3.74097576 |
| 36 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.73116391 |
| 37 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.71410611 |
| 38 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.71410611 |
| 39 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.70978924 |
| 40 | ribosomal small subunit assembly (GO:0000028) | 3.70258036 |
| 41 | DNA strand elongation (GO:0022616) | 3.69861964 |
| 42 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.68634723 |
| 43 | protein targeting to mitochondrion (GO:0006626) | 3.68567465 |
| 44 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.64496966 |
| 45 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.60728761 |
| 46 | aerobic respiration (GO:0009060) | 3.56220394 |
| 47 | respiratory chain complex IV assembly (GO:0008535) | 3.55349736 |
| 48 | mitotic chromosome condensation (GO:0007076) | 3.54470451 |
| 49 | termination of RNA polymerase III transcription (GO:0006386) | 3.52153877 |
| 50 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.52153877 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 3.51575291 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 3.51575291 |
| 53 | regulation of translational fidelity (GO:0006450) | 3.49480499 |
| 54 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.48637916 |
| 55 | mitochondrial fusion (GO:0008053) | 3.46758394 |
| 56 | establishment of protein localization to mitochondrion (GO:0072655) | 3.46528082 |
| 57 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.45540257 |
| 58 | ATP biosynthetic process (GO:0006754) | 3.42590862 |
| 59 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.41689132 |
| 60 | succinate metabolic process (GO:0006105) | 3.41479334 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.40770904 |
| 62 | COPI coating of Golgi vesicle (GO:0048205) | 3.38682440 |
| 63 | Golgi transport vesicle coating (GO:0048200) | 3.38682440 |
| 64 | inner mitochondrial membrane organization (GO:0007007) | 3.38514241 |
| 65 | cytochrome complex assembly (GO:0017004) | 3.37965519 |
| 66 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.37091663 |
| 67 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.35131337 |
| 68 | mitotic nuclear envelope reassembly (GO:0007084) | 3.33962525 |
| 69 | nuclear envelope reassembly (GO:0031468) | 3.33962525 |
| 70 | negative regulation of ligase activity (GO:0051352) | 3.33620201 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.33620201 |
| 72 | galactose catabolic process (GO:0019388) | 3.33309063 |
| 73 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.30094284 |
| 74 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.29514117 |
| 75 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.29514117 |
| 76 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.29448438 |
| 77 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.28585093 |
| 78 | NADPH regeneration (GO:0006740) | 3.28479225 |
| 79 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27577950 |
| 80 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.27363637 |
| 81 | glucose catabolic process (GO:0006007) | 3.27336547 |
| 82 | formation of translation preinitiation complex (GO:0001731) | 3.26652192 |
| 83 | purine nucleobase biosynthetic process (GO:0009113) | 3.26354153 |
| 84 | protein localization to mitochondrion (GO:0070585) | 3.25708657 |
| 85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.25534951 |
| 86 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.25534951 |
| 87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.25534951 |
| 88 | DNA replication initiation (GO:0006270) | 3.23796994 |
| 89 | signal peptide processing (GO:0006465) | 3.23597616 |
| 90 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.23551848 |
| 91 | regulation of early endosome to late endosome transport (GO:2000641) | 3.22163509 |
| 92 | metallo-sulfur cluster assembly (GO:0031163) | 3.21608699 |
| 93 | iron-sulfur cluster assembly (GO:0016226) | 3.21608699 |
| 94 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.17878550 |
| 95 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.17738193 |
| 96 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.16832471 |
| 97 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.16832471 |
| 98 | nucleobase biosynthetic process (GO:0046112) | 3.15112415 |
| 99 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.15007990 |
| 100 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.14998084 |
| 101 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.14998084 |
| 102 | regulation of oxidative phosphorylation (GO:0002082) | 3.13795496 |
| 103 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.13131323 |
| 104 | adenosine receptor signaling pathway (GO:0001973) | 3.12558677 |
| 105 | hydrogen ion transmembrane transport (GO:1902600) | 3.12285253 |
| 106 | GMP metabolic process (GO:0046037) | 3.11268974 |
| 107 | platelet aggregation (GO:0070527) | 3.10284809 |
| 108 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.09565017 |
| 109 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.09008021 |
| 110 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.08647925 |
| 111 | translation (GO:0006412) | 3.08635303 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.08237701 |
| 113 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.08073309 |
| 114 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.07971286 |
| 115 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.07971286 |
| 116 | ubiquinone biosynthetic process (GO:0006744) | 3.06873061 |
| 117 | quinone biosynthetic process (GO:1901663) | 3.06873061 |
| 118 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.03841398 |
| 119 | pentose metabolic process (GO:0019321) | 3.03240297 |
| 120 | cotranslational protein targeting to membrane (GO:0006613) | 3.02994397 |
| 121 | proline metabolic process (GO:0006560) | 3.02169360 |
| 122 | peptidyl-histidine modification (GO:0018202) | 3.00908116 |
| 123 | protein targeting to ER (GO:0045047) | 2.98740385 |
| 124 | mitochondrial transport (GO:0006839) | 2.97644417 |
| 125 | regulation of cellular respiration (GO:0043457) | 2.97569305 |
| 126 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.96909353 |
| 127 | protein neddylation (GO:0045116) | 2.96837473 |
| 128 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.96412586 |
| 129 | mitochondrial calcium ion transport (GO:0006851) | 2.94223161 |
| 130 | protein localization to endoplasmic reticulum (GO:0070972) | 2.93621102 |
| 131 | histone arginine methylation (GO:0034969) | 2.93453212 |
| 132 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.92774044 |
| 133 | peptidyl-arginine methylation (GO:0018216) | 2.92079040 |
| 134 | peptidyl-arginine N-methylation (GO:0035246) | 2.92079040 |
| 135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90081907 |
| 136 | polyamine biosynthetic process (GO:0006596) | 2.89779716 |
| 137 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.89617201 |
| 138 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.88604060 |
| 139 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.88604060 |
| 140 | protein localization to endosome (GO:0036010) | 2.86367269 |
| 141 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.86238310 |
| 142 | gluconeogenesis (GO:0006094) | 2.83595642 |
| 143 | regulation of chromatin binding (GO:0035561) | 2.82784187 |
| 144 | monosaccharide biosynthetic process (GO:0046364) | 2.82577935 |
| 145 | glucose 6-phosphate metabolic process (GO:0051156) | 2.72355884 |
| 146 | barbed-end actin filament capping (GO:0051016) | 2.72191505 |
| 147 | pyrimidine-containing compound salvage (GO:0008655) | 2.70878223 |
| 148 | pyrimidine nucleoside salvage (GO:0043097) | 2.70878223 |
| 149 | nucleotide salvage (GO:0043173) | 2.66669323 |
| 150 | glycolytic process (GO:0006096) | 2.64797374 |
| 151 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.63999875 |
| 152 | hexose biosynthetic process (GO:0019319) | 2.62623517 |
| 153 | protein complex localization (GO:0031503) | 2.61738326 |
| 154 | ribosomal small subunit biogenesis (GO:0042274) | 2.59481156 |
| 155 | cellular protein complex localization (GO:0034629) | 2.57732567 |
| 156 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.57678291 |
| 157 | rRNA transcription (GO:0009303) | 2.56699339 |
| 158 | folic acid metabolic process (GO:0046655) | 2.54185170 |
| 159 | protein retention in ER lumen (GO:0006621) | 2.51777112 |
| 160 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.49418564 |
| 161 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.46126961 |
| 162 | creatine metabolic process (GO:0006600) | 2.45764061 |
| 163 | regulation of mitochondrial membrane potential (GO:0051881) | 2.44853426 |
| 164 | platelet formation (GO:0030220) | 2.44419416 |
| 165 | cellular response to arsenic-containing substance (GO:0071243) | 2.42776624 |
| 166 | nuclear pore complex assembly (GO:0051292) | 2.42179417 |
| 167 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.39761384 |
| 168 | regulation of translational termination (GO:0006449) | 2.39308698 |
| 169 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.39044881 |
| 170 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.38277561 |
| 171 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.38175203 |
| 172 | adherens junction assembly (GO:0034333) | 2.37758261 |
| 173 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.36694424 |
| 174 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.33218894 |
| 175 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.33218894 |
| 176 | peptidyl-arginine modification (GO:0018195) | 2.32633646 |
| 177 | apoptotic process involved in morphogenesis (GO:0060561) | 2.32456174 |
| 178 | negative regulation of cell size (GO:0045792) | 2.31280959 |
| 179 | telomere maintenance via recombination (GO:0000722) | 2.30873254 |
| 180 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.30252476 |
| 181 | snRNA metabolic process (GO:0016073) | 2.30235180 |
| 182 | cell-substrate adherens junction assembly (GO:0007045) | 2.29729858 |
| 183 | focal adhesion assembly (GO:0048041) | 2.29729858 |
| 184 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.28671313 |
| 185 | UV protection (GO:0009650) | 2.28359835 |
| 186 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.28213066 |
| 187 | UMP biosynthetic process (GO:0006222) | 2.28213066 |
| 188 | UMP metabolic process (GO:0046049) | 2.28213066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.08160896 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.90371982 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.60669002 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.49664325 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.16474780 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.10438707 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.99000583 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.77443822 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.55821426 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.47691195 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.25349581 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.10569460 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 3.05507964 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.04959742 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.84848614 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.60422510 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.53744605 |
| 18 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.50661396 |
| 19 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.47437172 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.45516323 |
| 21 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.41002275 |
| 22 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.40058728 |
| 23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.40045559 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.30225422 |
| 25 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24464558 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.20689087 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.18141078 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17607917 |
| 29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.14843351 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.13327912 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.09725742 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.05183509 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04616621 |
| 34 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.02040444 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.94812690 |
| 36 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.89327673 |
| 37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.88696200 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87904945 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.81411488 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80976628 |
| 41 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.79798603 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78354729 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.74497014 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72883405 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.72439912 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72231979 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68350126 |
| 48 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.67964156 |
| 49 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66567868 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.65509626 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65197570 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64011102 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60210602 |
| 54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.59142151 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57751579 |
| 56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57196341 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57118366 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56883181 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.54578247 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.52362356 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50839150 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50425019 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48091494 |
| 64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.47413213 |
| 65 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.45458253 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41938452 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41671601 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41377671 |
| 69 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.40063403 |
| 70 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.38420235 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37922958 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.35230996 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34130303 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33611732 |
| 75 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.31863493 |
| 76 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29940292 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28275346 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28132735 |
| 79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26567708 |
| 80 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24687134 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24682421 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.24267516 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23642951 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23007878 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20794015 |
| 86 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.20428422 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19050580 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17614517 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17080975 |
| 90 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.16079866 |
| 91 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15728977 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15294379 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14478498 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.14317737 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14086178 |
| 96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12921817 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11689186 |
| 98 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11588570 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.10743926 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09342498 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08593022 |
| 102 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07737898 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.07169255 |
| 104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06497285 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05588357 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 1.03932977 |
| 107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02279018 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00902793 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00807431 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00447620 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99408137 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98707655 |
| 113 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.98218918 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98172373 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97572738 |
| 116 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90756683 |
| 117 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90432940 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89544439 |
| 119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89515345 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89439808 |
| 121 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.87798244 |
| 122 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87717904 |
| 123 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.86552478 |
| 124 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85455214 |
| 125 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.84741260 |
| 126 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.84414579 |
| 127 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.84401703 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84399688 |
| 129 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82987260 |
| 130 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.80644651 |
| 131 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.79762709 |
| 132 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79590759 |
| 133 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79478033 |
| 134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78318465 |
| 135 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.77870054 |
| 136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77683851 |
| 137 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.76527224 |
| 138 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75073443 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74494938 |
| 140 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.73847674 |
| 141 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72388524 |
| 142 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.71837411 |
| 143 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.71827073 |
| 144 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71057928 |
| 145 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.70310234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.54619403 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.23472011 |
| 3 | MP0005451_abnormal_body_composition | 3.99848526 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.96302907 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.60582402 |
| 6 | MP0000749_muscle_degeneration | 3.34481585 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.17268418 |
| 8 | MP0000751_myopathy | 3.07606755 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.76329124 |
| 10 | MP0002736_abnormal_nociception_after | 2.76143655 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.70146262 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.68753836 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.64957721 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.64033453 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.60600096 |
| 16 | MP0004147_increased_porphyrin_level | 2.58726336 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.58611914 |
| 18 | MP0006035_abnormal_mitochondrial_morpho | 2.56930930 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.48533152 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 2.45711745 |
| 21 | MP0003880_abnormal_central_pattern | 2.44726648 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 2.31895737 |
| 23 | MP0009379_abnormal_foot_pigmentation | 2.23796009 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.23010950 |
| 25 | MP0003566_abnormal_cell_adhesion | 2.21326080 |
| 26 | MP0010094_abnormal_chromosome_stability | 2.09361137 |
| 27 | MP0008932_abnormal_embryonic_tissue | 2.06321517 |
| 28 | MP0003693_abnormal_embryo_hatching | 2.06243056 |
| 29 | MP0005330_cardiomyopathy | 2.03098571 |
| 30 | MP0001661_extended_life_span | 2.01552410 |
| 31 | MP0002876_abnormal_thyroid_physiology | 2.00613676 |
| 32 | MP0003077_abnormal_cell_cycle | 1.96831880 |
| 33 | MP0005501_abnormal_skin_physiology | 1.96772745 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.89778596 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.83453781 |
| 36 | MP0001529_abnormal_vocalization | 1.81566645 |
| 37 | MP0003186_abnormal_redox_activity | 1.75358073 |
| 38 | MP0004859_abnormal_synaptic_plasticity | 1.74455930 |
| 39 | MP0001730_embryonic_growth_arrest | 1.68332298 |
| 40 | MP0001849_ear_inflammation | 1.67605366 |
| 41 | MP0004043_abnormal_pH_regulation | 1.65566448 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.65465458 |
| 43 | MP0000747_muscle_weakness | 1.63568747 |
| 44 | MP0003879_abnormal_hair_cell | 1.60918744 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.60777398 |
| 46 | MP0002822_catalepsy | 1.58537020 |
| 47 | MP0000343_altered_response_to | 1.57653106 |
| 48 | MP0002269_muscular_atrophy | 1.56661221 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.46687339 |
| 50 | MP0003195_calcinosis | 1.43799352 |
| 51 | MP0001984_abnormal_olfaction | 1.43177858 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.43163226 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.41579847 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.41218946 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.40188923 |
| 56 | MP0005666_abnormal_adipose_tissue | 1.40005038 |
| 57 | MP0000350_abnormal_cell_proliferation | 1.39408858 |
| 58 | MP0004270_analgesia | 1.38913914 |
| 59 | MP0005620_abnormal_muscle_contractility | 1.38002831 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.37837575 |
| 61 | MP0002796_impaired_skin_barrier | 1.34783168 |
| 62 | MP0002972_abnormal_cardiac_muscle | 1.34735670 |
| 63 | MP0001764_abnormal_homeostasis | 1.34210514 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.34123430 |
| 65 | MP0002272_abnormal_nervous_system | 1.33898692 |
| 66 | MP0002106_abnormal_muscle_physiology | 1.33360144 |
| 67 | MP0000858_altered_metastatic_potential | 1.32245590 |
| 68 | MP0004510_myositis | 1.30976717 |
| 69 | MP0000313_abnormal_cell_death | 1.30756388 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 1.29411105 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.29283501 |
| 72 | MP0001664_abnormal_digestion | 1.29264413 |
| 73 | MP0000490_abnormal_crypts_of | 1.28188940 |
| 74 | MP0004130_abnormal_muscle_cell | 1.27916355 |
| 75 | MP0009840_abnormal_foam_cell | 1.26211259 |
| 76 | MP0001905_abnormal_dopamine_level | 1.26081394 |
| 77 | MP0002064_seizures | 1.25874499 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.25484360 |
| 79 | MP0001346_abnormal_lacrimal_gland | 1.23381159 |
| 80 | MP0002080_prenatal_lethality | 1.22951876 |
| 81 | MP0008004_abnormal_stomach_pH | 1.22542535 |
| 82 | MP0003137_abnormal_impulse_conducting | 1.22072349 |
| 83 | MP0008007_abnormal_cellular_replicative | 1.22001332 |
| 84 | MP0004087_abnormal_muscle_fiber | 1.20687454 |
| 85 | MP0000759_abnormal_skeletal_muscle | 1.20095761 |
| 86 | MP0002132_abnormal_respiratory_system | 1.18495673 |
| 87 | MP0009745_abnormal_behavioral_response | 1.18434054 |
| 88 | MP0005636_abnormal_mineral_homeostasis | 1.17056657 |
| 89 | MP0000537_abnormal_urethra_morphology | 1.14895448 |
| 90 | MP0009046_muscle_twitch | 1.14806015 |
| 91 | MP0001970_abnormal_pain_threshold | 1.13428268 |
| 92 | MP0005266_abnormal_metabolism | 1.13143222 |
| 93 | MP0005646_abnormal_pituitary_gland | 1.13016945 |
| 94 | MP0003786_premature_aging | 1.11707656 |
| 95 | MP0004142_abnormal_muscle_tone | 1.10874924 |
| 96 | MP0000733_abnormal_muscle_development | 1.10045424 |
| 97 | MP0008775_abnormal_heart_ventricle | 1.08790544 |
| 98 | MP0005083_abnormal_biliary_tract | 1.08785315 |
| 99 | MP0010630_abnormal_cardiac_muscle | 1.08675596 |
| 100 | MP0000358_abnormal_cell_content/ | 1.08263984 |
| 101 | MP0009278_abnormal_bone_marrow | 1.07757345 |
| 102 | MP0005369_muscle_phenotype | 1.07258907 |
| 103 | MP0009697_abnormal_copulation | 1.06964890 |
| 104 | MP0003183_abnormal_peptide_metabolism | 1.06505309 |
| 105 | MP0005623_abnormal_meninges_morphology | 1.03655903 |
| 106 | MP0005385_cardiovascular_system_phenoty | 1.03634728 |
| 107 | MP0001544_abnormal_cardiovascular_syste | 1.03634728 |
| 108 | MP0001697_abnormal_embryo_size | 1.03282367 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01926348 |
| 110 | MP0008872_abnormal_physiological_respon | 1.01715086 |
| 111 | MP0008874_decreased_physiological_sensi | 1.00903309 |
| 112 | MP0005621_abnormal_cell_physiology | 1.00668974 |
| 113 | MP0000003_abnormal_adipose_tissue | 1.00414075 |
| 114 | MP0004085_abnormal_heartbeat | 1.00046400 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99642743 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.99429919 |
| 117 | MP0002063_abnormal_learning/memory/cond | 0.99270319 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.98719109 |
| 119 | MP0002163_abnormal_gland_morphology | 0.98445945 |
| 120 | MP0009672_abnormal_birth_weight | 0.96861611 |
| 121 | MP0005384_cellular_phenotype | 0.94779370 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.94205306 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.93727758 |
| 124 | MP0002572_abnormal_emotion/affect_behav | 0.93654026 |
| 125 | MP0004924_abnormal_behavior | 0.93573065 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.93573065 |
| 127 | MP0010386_abnormal_urinary_bladder | 0.93283424 |
| 128 | MP0005397_hematopoietic_system_phenotyp | 0.91921529 |
| 129 | MP0001545_abnormal_hematopoietic_system | 0.91921529 |
| 130 | MP0002249_abnormal_larynx_morphology | 0.91850045 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.91794248 |
| 132 | MP0005076_abnormal_cell_differentiation | 0.90645005 |
| 133 | MP0005332_abnormal_amino_acid | 0.90183395 |
| 134 | MP0002638_abnormal_pupillary_reflex | 0.89980224 |
| 135 | MP0005380_embryogenesis_phenotype | 0.89422918 |
| 136 | MP0001672_abnormal_embryogenesis/_devel | 0.89422918 |
| 137 | MP0003123_paternal_imprinting | 0.88889803 |
| 138 | MP0008058_abnormal_DNA_repair | 0.88802005 |
| 139 | MP0008260_abnormal_autophagy | 0.88435917 |
| 140 | MP0008569_lethality_at_weaning | 0.87535866 |
| 141 | MP0004484_altered_response_of | 0.87225130 |
| 142 | MP0002733_abnormal_thermal_nociception | 0.86977729 |
| 143 | MP0002019_abnormal_tumor_incidence | 0.85094710 |
| 144 | MP0003984_embryonic_growth_retardation | 0.84488552 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.84329954 |
| 146 | MP0009780_abnormal_chondrocyte_physiolo | 0.84270725 |
| 147 | MP0005535_abnormal_body_temperature | 0.83428590 |
| 148 | MP0005165_increased_susceptibility_to | 0.82150061 |
| 149 | MP0002086_abnormal_extraembryonic_tissu | 0.82136711 |
| 150 | MP0000703_abnormal_thymus_morphology | 0.81768543 |
| 151 | MP0005319_abnormal_enzyme/_coenzyme | 0.79418593 |
| 152 | MP0006054_spinal_hemorrhage | 0.78713592 |
| 153 | MP0004947_skin_inflammation | 0.78199656 |
| 154 | MP0002088_abnormal_embryonic_growth/wei | 0.75057609 |
| 155 | MP0002398_abnormal_bone_marrow | 0.74103536 |
| 156 | MP0009931_abnormal_skin_appearance | 0.73903970 |
| 157 | MP0005220_abnormal_exocrine_pancreas | 0.73550488 |
| 158 | MP0005376_homeostasis/metabolism_phenot | 0.72572193 |
| 159 | MP0000467_abnormal_esophagus_morphology | 0.72031651 |
| 160 | MP0000681_abnormal_thyroid_gland | 0.71390345 |
| 161 | MP0003763_abnormal_thymus_physiology | 0.70234269 |
| 162 | MP0004233_abnormal_muscle_weight | 0.70005695 |
| 163 | MP0001663_abnormal_digestive_system | 0.69321185 |
| 164 | MP0006138_congestive_heart_failure | 0.69055091 |
| 165 | MP0002078_abnormal_glucose_homeostasis | 0.68673955 |
| 166 | MP0002332_abnormal_exercise_endurance | 0.65326432 |
| 167 | MP0000372_irregular_coat_pigmentation | 0.65222227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.62262476 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.59015276 |
| 3 | Hepatocellular necrosis (HP:0001404) | 5.46810879 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.36440729 |
| 5 | Hepatic necrosis (HP:0002605) | 5.34243159 |
| 6 | Increased CSF lactate (HP:0002490) | 5.04504292 |
| 7 | Acute encephalopathy (HP:0006846) | 4.81667083 |
| 8 | Petechiae (HP:0000967) | 4.63515709 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.42291806 |
| 10 | Abnormality of glycolysis (HP:0004366) | 4.33743837 |
| 11 | Increased serum pyruvate (HP:0003542) | 4.33743837 |
| 12 | Increased mean platelet volume (HP:0011877) | 3.95952889 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.91131576 |
| 14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.91131576 |
| 15 | Lactic acidosis (HP:0003128) | 3.90628464 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.89033639 |
| 17 | Prolonged bleeding time (HP:0003010) | 3.86611691 |
| 18 | Increased serum lactate (HP:0002151) | 3.83555399 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.78523697 |
| 20 | Neuroendocrine neoplasm (HP:0100634) | 3.76799296 |
| 21 | Distal lower limb amyotrophy (HP:0008944) | 3.76691208 |
| 22 | Menorrhagia (HP:0000132) | 3.73977973 |
| 23 | Abnormal platelet volume (HP:0011876) | 3.73454684 |
| 24 | Lipid accumulation in hepatocytes (HP:0006561) | 3.71197055 |
| 25 | Pheochromocytoma (HP:0002666) | 3.68543809 |
| 26 | Purpura (HP:0000979) | 3.66621669 |
| 27 | Exercise intolerance (HP:0003546) | 3.65335688 |
| 28 | Increased muscle lipid content (HP:0009058) | 3.63345156 |
| 29 | Abnormal gallbladder physiology (HP:0012438) | 3.58107058 |
| 30 | Cholecystitis (HP:0001082) | 3.58107058 |
| 31 | Increased connective tissue (HP:0009025) | 3.56552601 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.47382395 |
| 33 | Nemaline bodies (HP:0003798) | 3.44677363 |
| 34 | Respiratory failure (HP:0002878) | 3.42442645 |
| 35 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.38547596 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 3.37501782 |
| 37 | Cerebral edema (HP:0002181) | 3.37463643 |
| 38 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.36355036 |
| 39 | Myopathic facies (HP:0002058) | 3.31098142 |
| 40 | Cerebral hypomyelination (HP:0006808) | 3.20475889 |
| 41 | Truncus arteriosus (HP:0001660) | 3.16053062 |
| 42 | 3-Methylglutaconic aciduria (HP:0003535) | 3.15415208 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 3.08694690 |
| 44 | CNS demyelination (HP:0007305) | 3.05064634 |
| 45 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.03778492 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.99465958 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.99465958 |
| 48 | Hyperalaninemia (HP:0003348) | 2.99465958 |
| 49 | Impaired platelet aggregation (HP:0003540) | 2.98733657 |
| 50 | Abnormal platelet function (HP:0011869) | 2.98733657 |
| 51 | Palpitations (HP:0001962) | 2.96266297 |
| 52 | Hyperthyroidism (HP:0000836) | 2.84818735 |
| 53 | Emotional lability (HP:0000712) | 2.84137744 |
| 54 | Ragged-red muscle fibers (HP:0003200) | 2.77433569 |
| 55 | Reticulocytosis (HP:0001923) | 2.76581294 |
| 56 | Abnormality of the Achilles tendon (HP:0005109) | 2.75752385 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.75212849 |
| 58 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.73130595 |
| 59 | Achilles tendon contracture (HP:0001771) | 2.69602688 |
| 60 | Myoglobinuria (HP:0002913) | 2.66517512 |
| 61 | Lower limb amyotrophy (HP:0007210) | 2.64006915 |
| 62 | Respiratory difficulties (HP:0002880) | 2.60542614 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.56830806 |
| 64 | Paralysis (HP:0003470) | 2.55563714 |
| 65 | Exercise-induced muscle cramps (HP:0003710) | 2.54950944 |
| 66 | Exercise-induced myalgia (HP:0003738) | 2.53470640 |
| 67 | Optic disc pallor (HP:0000543) | 2.52623176 |
| 68 | Epistaxis (HP:0000421) | 2.49553983 |
| 69 | Leukodystrophy (HP:0002415) | 2.47266772 |
| 70 | Exertional dyspnea (HP:0002875) | 2.46678097 |
| 71 | Abnormal number of erythroid precursors (HP:0012131) | 2.45327467 |
| 72 | Lethargy (HP:0001254) | 2.45144962 |
| 73 | Sudden death (HP:0001699) | 2.44062644 |
| 74 | Unsteady gait (HP:0002317) | 2.43573935 |
| 75 | Progressive muscle weakness (HP:0003323) | 2.43438029 |
| 76 | Aplastic anemia (HP:0001915) | 2.39458746 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.39281091 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39281091 |
| 79 | Myotonia (HP:0002486) | 2.35571510 |
| 80 | Poor suck (HP:0002033) | 2.34029925 |
| 81 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.32802667 |
| 82 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.31706317 |
| 83 | Type I transferrin isoform profile (HP:0003642) | 2.31600330 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 2.31190526 |
| 85 | Neoplasm of the adrenal gland (HP:0100631) | 2.25702811 |
| 86 | Rhabdomyolysis (HP:0003201) | 2.24063883 |
| 87 | Type 1 muscle fiber predominance (HP:0003803) | 2.23738223 |
| 88 | Abnormal large intestine physiology (HP:0012700) | 2.22688935 |
| 89 | Hypokinesia (HP:0002375) | 2.21583646 |
| 90 | Abnormality of the tricuspid valve (HP:0001702) | 2.20987878 |
| 91 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.20770082 |
| 92 | Methylmalonic aciduria (HP:0012120) | 2.20621341 |
| 93 | Microvesicular hepatic steatosis (HP:0001414) | 2.20554873 |
| 94 | Abnormality of the umbilical cord (HP:0010881) | 2.20254395 |
| 95 | Abnormality of reticulocytes (HP:0004312) | 2.19906636 |
| 96 | Calf muscle hypertrophy (HP:0008981) | 2.17947379 |
| 97 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.17397438 |
| 98 | EMG: myopathic abnormalities (HP:0003458) | 2.17117869 |
| 99 | Progressive external ophthalmoplegia (HP:0000590) | 2.16769359 |
| 100 | Bulbar palsy (HP:0001283) | 2.11767436 |
| 101 | Irregular epiphyses (HP:0010582) | 2.10281576 |
| 102 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.09089156 |
| 103 | Hypertensive crisis (HP:0100735) | 2.08458597 |
| 104 | Conjunctival hamartoma (HP:0100780) | 2.08023585 |
| 105 | Trismus (HP:0000211) | 2.07601562 |
| 106 | Gout (HP:0001997) | 2.06161799 |
| 107 | Glycosuria (HP:0003076) | 2.05722291 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 2.05722291 |
| 109 | Back pain (HP:0003418) | 2.03635991 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.02420526 |
| 111 | Septate vagina (HP:0001153) | 2.02193810 |
| 112 | Epileptic encephalopathy (HP:0200134) | 2.01645214 |
| 113 | Upper limb muscle weakness (HP:0003484) | 2.01622088 |
| 114 | Gliosis (HP:0002171) | 2.01154145 |
| 115 | Hypoplasia of the uterus (HP:0000013) | 2.00536600 |
| 116 | Bowel incontinence (HP:0002607) | 1.99756343 |
| 117 | Muscle stiffness (HP:0003552) | 1.98920513 |
| 118 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97367748 |
| 119 | Neck muscle weakness (HP:0000467) | 1.95666984 |
| 120 | Oral leukoplakia (HP:0002745) | 1.94771243 |
| 121 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.94766407 |
| 122 | Difficulty climbing stairs (HP:0003551) | 1.93116984 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.91746703 |
| 124 | Abnormality of lateral ventricle (HP:0030047) | 1.91568378 |
| 125 | Cholelithiasis (HP:0001081) | 1.91494831 |
| 126 | Fatigue (HP:0012378) | 1.91477799 |
| 127 | Spinal rigidity (HP:0003306) | 1.91180203 |
| 128 | Hyperventilation (HP:0002883) | 1.90251646 |
| 129 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88292219 |
| 130 | X-linked dominant inheritance (HP:0001423) | 1.87216676 |
| 131 | Hyperacusis (HP:0010780) | 1.86866174 |
| 132 | Broad distal phalanx of finger (HP:0009836) | 1.86509913 |
| 133 | Delusions (HP:0000746) | 1.85606074 |
| 134 | CNS hypomyelination (HP:0003429) | 1.84727648 |
| 135 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84726738 |
| 136 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84726738 |
| 137 | Abnormal protein glycosylation (HP:0012346) | 1.84726738 |
| 138 | Abnormal glycosylation (HP:0012345) | 1.84726738 |
| 139 | Esophageal neoplasm (HP:0100751) | 1.83640258 |
| 140 | Neoplasm of head and neck (HP:0012288) | 1.83640258 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83474587 |
| 142 | Vomiting (HP:0002013) | 1.83232375 |
| 143 | Increased serum ferritin (HP:0003281) | 1.83002683 |
| 144 | Focal motor seizures (HP:0011153) | 1.82039065 |
| 145 | Abnormal gallbladder morphology (HP:0012437) | 1.81998368 |
| 146 | Abnormality of renal resorption (HP:0011038) | 1.80337293 |
| 147 | Abnormality of the gallbladder (HP:0005264) | 1.79870673 |
| 148 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78720629 |
| 149 | Polycythemia (HP:0001901) | 1.78548882 |
| 150 | Calcaneovalgus deformity (HP:0001848) | 1.77772978 |
| 151 | Microretrognathia (HP:0000308) | 1.77622895 |
| 152 | Generalized amyotrophy (HP:0003700) | 1.75708712 |
| 153 | Hypoparathyroidism (HP:0000829) | 1.74949101 |
| 154 | Hyporeflexia of lower limbs (HP:0002600) | 1.74502974 |
| 155 | Postnatal microcephaly (HP:0005484) | 1.74489705 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.73667855 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.73667855 |
| 158 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73543749 |
| 159 | Oligomenorrhea (HP:0000876) | 1.73120753 |
| 160 | Foot dorsiflexor weakness (HP:0009027) | 1.72583034 |
| 161 | Termporal pattern (HP:0011008) | 1.71883248 |
| 162 | Insidious onset (HP:0003587) | 1.71883248 |
| 163 | Testicular atrophy (HP:0000029) | 1.71022987 |
| 164 | Hyperphosphaturia (HP:0003109) | 1.70832071 |
| 165 | Poikilocytosis (HP:0004447) | 1.70535076 |
| 166 | Tinnitus (HP:0000360) | 1.70258425 |
| 167 | Single umbilical artery (HP:0001195) | 1.69928261 |
| 168 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.69928261 |
| 169 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.69928261 |
| 170 | Nausea (HP:0002018) | 1.69327888 |
| 171 | Abnormality of the calcaneus (HP:0008364) | 1.68934978 |
| 172 | Poor head control (HP:0002421) | 1.68223949 |
| 173 | Hypoplasia of the pons (HP:0012110) | 1.68183714 |
| 174 | Stridor (HP:0010307) | 1.68090008 |
| 175 | Muscle fiber inclusion bodies (HP:0100299) | 1.68021889 |
| 176 | Seborrheic dermatitis (HP:0001051) | 1.67611064 |
| 177 | Orthostatic hypotension (HP:0001278) | 1.66644986 |
| 178 | Rough bone trabeculation (HP:0100670) | 1.63996381 |
| 179 | Breast hypoplasia (HP:0003187) | 1.63258085 |
| 180 | Male infertility (HP:0003251) | 1.62858527 |
| 181 | Ankyloglossia (HP:0010296) | 1.61909748 |
| 182 | Acanthocytosis (HP:0001927) | 1.61581984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.88798223 |
| 2 | TRIB3 | 3.74061852 |
| 3 | EIF2AK1 | 3.49242549 |
| 4 | BUB1 | 3.14907386 |
| 5 | CCNB1 | 3.14760467 |
| 6 | SMG1 | 2.97827502 |
| 7 | MAP3K12 | 2.86330153 |
| 8 | CASK | 2.84600398 |
| 9 | BCKDK | 2.50602229 |
| 10 | NME2 | 2.38275677 |
| 11 | NEK1 | 2.32147698 |
| 12 | MYLK | 2.31509802 |
| 13 | NME1 | 2.26383136 |
| 14 | LMTK2 | 2.25432200 |
| 15 | CDK19 | 2.19323268 |
| 16 | EEF2K | 2.17903099 |
| 17 | DAPK1 | 2.11913601 |
| 18 | PIM2 | 1.95177611 |
| 19 | BMX | 1.86443591 |
| 20 | TSSK6 | 1.86432280 |
| 21 | PRPF4B | 1.79920130 |
| 22 | MAP2K7 | 1.79764309 |
| 23 | PDK3 | 1.78225801 |
| 24 | PDK4 | 1.78225801 |
| 25 | MUSK | 1.76288268 |
| 26 | ICK | 1.73775321 |
| 27 | SIK1 | 1.72980132 |
| 28 | VRK2 | 1.71016400 |
| 29 | SIK3 | 1.65786897 |
| 30 | WEE1 | 1.62558831 |
| 31 | ARAF | 1.61049538 |
| 32 | EIF2AK3 | 1.60512660 |
| 33 | OBSCN | 1.57987452 |
| 34 | EPHA2 | 1.51923542 |
| 35 | RIPK4 | 1.50704127 |
| 36 | FLT3 | 1.46758397 |
| 37 | VRK1 | 1.45754447 |
| 38 | MST1R | 1.45368226 |
| 39 | BRAF | 1.44917433 |
| 40 | BRSK1 | 1.44095275 |
| 41 | KSR2 | 1.43295790 |
| 42 | CAMKK2 | 1.42544963 |
| 43 | AKT3 | 1.42367460 |
| 44 | DAPK2 | 1.36409909 |
| 45 | SCYL2 | 1.34902201 |
| 46 | PHKG1 | 1.31584078 |
| 47 | PHKG2 | 1.31584078 |
| 48 | PAK4 | 1.25583637 |
| 49 | TAOK2 | 1.23288037 |
| 50 | LIMK1 | 1.22866537 |
| 51 | PLK2 | 1.17341800 |
| 52 | PINK1 | 1.14523027 |
| 53 | MAP3K8 | 1.13004466 |
| 54 | TESK1 | 1.11206322 |
| 55 | IRAK2 | 1.10811999 |
| 56 | PKN2 | 1.10448696 |
| 57 | BRSK2 | 1.08977445 |
| 58 | MINK1 | 1.08324819 |
| 59 | MAP3K11 | 1.08037821 |
| 60 | TLK1 | 1.06375182 |
| 61 | ILK | 0.99154902 |
| 62 | PAK1 | 0.97011085 |
| 63 | TESK2 | 0.94365516 |
| 64 | DAPK3 | 0.93664297 |
| 65 | MAP2K6 | 0.93312251 |
| 66 | NTRK3 | 0.91836344 |
| 67 | PDK2 | 0.90646023 |
| 68 | PRKD3 | 0.88273563 |
| 69 | CDK8 | 0.85654847 |
| 70 | CDK7 | 0.84499326 |
| 71 | MAPK11 | 0.82237555 |
| 72 | PLK4 | 0.81494308 |
| 73 | RPS6KB2 | 0.80701336 |
| 74 | MAPKAPK3 | 0.79149708 |
| 75 | PDPK1 | 0.78318868 |
| 76 | TAOK1 | 0.76625431 |
| 77 | LRRK2 | 0.76301366 |
| 78 | MAP3K1 | 0.74325338 |
| 79 | PRKG2 | 0.73545576 |
| 80 | CDC7 | 0.73179998 |
| 81 | STK4 | 0.72892556 |
| 82 | ACVR1B | 0.72648469 |
| 83 | TNIK | 0.72078078 |
| 84 | GRK5 | 0.71069204 |
| 85 | ABL2 | 0.70615267 |
| 86 | AKT2 | 0.68206402 |
| 87 | TTK | 0.67569355 |
| 88 | STK24 | 0.63463376 |
| 89 | RAF1 | 0.63421799 |
| 90 | KDR | 0.60777314 |
| 91 | MAP3K10 | 0.58897044 |
| 92 | SRPK1 | 0.58820903 |
| 93 | CHEK2 | 0.58312631 |
| 94 | AURKA | 0.56896759 |
| 95 | GRK7 | 0.52368937 |
| 96 | MAP2K4 | 0.52037893 |
| 97 | CAMK2D | 0.50747377 |
| 98 | PBK | 0.47757473 |
| 99 | GRK6 | 0.47735281 |
| 100 | IRAK3 | 0.46840515 |
| 101 | CLK1 | 0.46740343 |
| 102 | OXSR1 | 0.46593410 |
| 103 | CAMK1 | 0.44757065 |
| 104 | PRKCG | 0.44567963 |
| 105 | CDK4 | 0.44405825 |
| 106 | EPHA4 | 0.44113507 |
| 107 | MST4 | 0.44104943 |
| 108 | CAMK2B | 0.43850493 |
| 109 | TTN | 0.43749621 |
| 110 | MAP3K4 | 0.43183243 |
| 111 | CDK18 | 0.43150001 |
| 112 | BCR | 0.43126205 |
| 113 | CAMK2G | 0.41929539 |
| 114 | UHMK1 | 0.41829926 |
| 115 | AURKB | 0.41677024 |
| 116 | PLK3 | 0.41574608 |
| 117 | CDK14 | 0.40483732 |
| 118 | MAP3K5 | 0.40050095 |
| 119 | MTOR | 0.39993682 |
| 120 | CDK12 | 0.38752842 |
| 121 | MET | 0.37696749 |
| 122 | EPHB1 | 0.36865891 |
| 123 | ZAP70 | 0.36736153 |
| 124 | MAP2K2 | 0.36473580 |
| 125 | ADRBK1 | 0.35987429 |
| 126 | MAP2K3 | 0.35851399 |
| 127 | BTK | 0.35712575 |
| 128 | CSNK2A1 | 0.35146386 |
| 129 | PRKCI | 0.33804883 |
| 130 | PTK2 | 0.33596161 |
| 131 | CAMK2A | 0.32621659 |
| 132 | CDK15 | 0.31709885 |
| 133 | CDK11A | 0.31299254 |
| 134 | MAP3K13 | 0.31063156 |
| 135 | MAP3K2 | 0.30668599 |
| 136 | PRKACA | 0.29910532 |
| 137 | NEK9 | 0.28072428 |
| 138 | PLK1 | 0.28039644 |
| 139 | KSR1 | 0.27333305 |
| 140 | DYRK2 | 0.27303668 |
| 141 | MAP2K1 | 0.26553366 |
| 142 | ERN1 | 0.25562223 |
| 143 | CSNK2A2 | 0.24116806 |
| 144 | MAPK12 | 0.22981347 |
| 145 | IRAK4 | 0.22752719 |
| 146 | MAP3K3 | 0.22393141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.59419266 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.59047096 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.17503837 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 4.09285598 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.24384962 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.79612003 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.77744404 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.77332710 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.64326634 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.54085970 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.25579636 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.16812859 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.11289182 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.91784630 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.89243587 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.85031118 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84947354 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.83821276 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69621655 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.68678470 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60242642 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.59781485 |
| 23 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.54581397 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52400571 |
| 25 | Bladder cancer_Homo sapiens_hsa05219 | 1.50561698 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45658358 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.44221979 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43653861 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41096547 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38869961 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37305351 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35993812 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.35296922 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33554232 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31873181 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.31342132 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30154835 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.27038827 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.26613568 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21790146 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21430685 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.20137707 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.20017053 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.19656416 |
| 45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.18576255 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 1.17980109 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14861771 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10120983 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09364110 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 1.09342097 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.06831950 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99726051 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99144152 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98988826 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97743422 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97296557 |
| 57 | Alcoholism_Homo sapiens_hsa05034 | 0.95426401 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92694203 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.91663831 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90276614 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89351518 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89104687 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89049481 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88375844 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.86382789 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.85179147 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.82649802 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81321474 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77002717 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76267630 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 0.74274325 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72309801 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.70731343 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68430549 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65495307 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64995075 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63494216 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62124754 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61637554 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61553096 |
| 81 | Nicotine addiction_Homo sapiens_hsa05033 | 0.60632711 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60379433 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59596416 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59305610 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57769416 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56934539 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.55865933 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55794199 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53360664 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53081790 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52591930 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52462294 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51394696 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51026432 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50564488 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.50235119 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48173022 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.45418663 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44616369 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44546394 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44435926 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44331746 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43772831 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.42707025 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.41986044 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41780122 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41310286 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40831599 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.40784297 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.40272390 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40245224 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39845751 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39837988 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39271951 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38539789 |
| 116 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.38327844 |
| 117 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36482197 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.35198790 |
| 119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.34622896 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.33680840 |
| 121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33313749 |
| 122 | Legionellosis_Homo sapiens_hsa05134 | 0.31758019 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31220021 |
| 124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30885159 |
| 125 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29649373 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.28563739 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27661751 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.27426563 |
| 129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26514406 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26118430 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25555158 |
| 132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.25491700 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24177981 |
| 134 | Morphine addiction_Homo sapiens_hsa05032 | 0.23654669 |
| 135 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22747201 |
| 136 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.22700687 |
| 137 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22276207 |
| 138 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.21128688 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19051134 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18036581 |
| 141 | Basal transcription factors_Homo sapiens_hsa03022 | 0.17153875 |
| 142 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.17003099 |
| 143 | Cell cycle_Homo sapiens_hsa04110 | 0.15530080 |
| 144 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.15404339 |
| 145 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13812342 |
| 146 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13492902 |

